Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Beta Drugs Ltd.
NSE: BETA
|
BSE: 531481
|
ISIN: INE351Y01019
|
Industry: Pharmaceuticals
|
Expensive Rocket
2153.4000
62.90
(
3.01
%)
NSE
Jul 06, 2026
15:50 PM
Near 52W High of ₹2250.00
Volume:
23,455
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Beta Drugs Ltd.
08 Nov 2024
2153.40
3.01%
Beta Drugs | H1FY25 Result Update
Buy:
Beta Drugs Ltd.
by
Edelweiss
Target: 2245
Target
Edelweiss
Strong show in H1; near-term growth factored in
Beta Drugs Ltd. is trading above all available SMAs
More from Beta Drugs Ltd.
Recommended
Market closes higher on gains in banking stocks and foreign fund inflows
Trendlyne Marketwatch |
06 Jul 2026, 04:05PM
Five Interesting Stocks Today - July 3, 2026
The Baseline |
03 Jul 2026
Q1FY27: What's driving the strongest growth forecasts?
The Baseline |
02 Jul 2026